An endogenous peptide and NTS receptor ligand
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Xenin-25 (acetate)

Item No. 45528

Technical Information
Formal Name
L-methionyl-L-leucyl-L-threonyl-L-lysyl-L-phenylalanyl-L-α-glutamyl-L-threonyl-L-lysyl-L-seryl-L-alanyl-L-arginyl-L-valyl-L-lysylglycyl-L-leucyl-L-seryl-L-phenylalanyl-L-histidyl-L-prolyl-L-lysyl-L-arginyl-L-prolyl-L-tryptophyl-L-isoleucyl-L-leucine, acetate
Synonyms
  • Xenopsin-25
Molecular Formula
C139H224N38O32S • XC2H4O2
Formula Weight
Purity
≥98%
A solid
Peptide Sequence
H-MLTKFETLSARVKGLSFHPKRPWIL-OH
Acetonitrile:Water (1:1): Sparingly soluble: 1-10 mg/ml
SMILES
O=C(N[C@H](C(N[C@]([C@H](O[H])C)([H])C(N[C@@H](CCCCN[H])C(N[C@H](C(N[C@@H](CCC(O)=O)C(N[C@]([C@H](O[H])C)([H])C(N[C@@H](CCCCN[H])C(N[C@@H](CO[H])C(N[C@H](C(N[C@@H](CCC/N=C(N[H])/N)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN[H])C(NCC(N[C@H](C(N[C@@H](CO[H])C(N[C@H](C(N[C@@H](CC1=CN([H])C=N1)C(N2CCC[C@H]2C(N[C@@H](CCCCN[H])C(N[C@@H](CCC/N=C(N[H])/N)C(N3CCC[C@H]3C(N[C@@H](CC4=CN([H])C5=C4C=CC=C5)C(N[C@@](C(N[C@H](C(O)=O)CC(C)C)=O)([H])[C@@H](C)CC)=O)=O)=O)=O)=O)=O)=O)CC6=CC=CC=C6)=O)=O)CC(C)C)=O)=O)=O)=O)=O)C)=O)=O)=O)=O)=O)CC7=CC=CC=C7)=O)=O)=O)CC(C)C)[C@H](CCSC)N[H].CC(O)=O
InChi Code
InChI=1S/C139H224N38O32S.C2H4O2/c1-15-79(10)111(132(203)169-103(137(208)209)64-77(6)7)173-126(197)101(67-85-69-152-89-41-23-22-40-87(85)89)167-130(201)107-49-34-59-176(107)135(206)96(47-33-58-151-139(147)148)163-117(188)91(43-25-29-54-141)159-129(200)106-48-35-60-177(106)136(207)102(68-86-70-149-74-154-86)168-124(195)100(66-84-38-20-17-21-39-84)166-128(199)105(73-179)171-122(193)97(62-75(2)3)156-108(182)71-153-116(187)90(42-24-28-53-140)160-131(202)110(78(8)9)172-120(191)94(46-32-57-150-138(145)146)157-114(185)80(11)155-127(198)104(72-178)170-119(190)93(45-27-31-56-143)162-133(204)112(81(12)180)174-121(192)95(50-51-109(183)184)158-123(194)99(65-83-36-18-16-19-37-83)165-118(189)92(44-26-30-55-142)161-134(205)113(82(13)181)175-125(196)98(63-76(4)5)164-115(186)88(144)52-61-210-14;1-2(3)4/h16-23,36-41,69-70,74-82,88,90-107,110-113,152,178-181H,15,24-35,42-68,71-73,140-144H2,1-14H3,(H,149,154)(H,153,187)(H,155,198)(H,156,182)(H,157,185)(H,158,194)(H,159,200)(H,160,202)(H,161,205)(H,162,204)(H,163,188)(H,164,186)(H,165,189)(H,166,199)(H,167,201)(H,168,195)(H,169,203)(H,170,190)(H,171,193)(H,172,191)(H,173,197)(H,174,192)(H,175,196)(H,183,184)(H,208,209)(H4,145,146,150)(H4,147,148,151);1H3,(H,3,4)/t79-,80-,81+,82+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,110-,111-,112-,113-;/m0./s1
InChi Key
RZITYMYGJDRACU-OQVOPOPSSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    Xenin-25 is an endogenous peptide and a neurotensin (NTS) receptor ligand.1 It binds to NTS receptors in HEK293 cell membranes expressing the mouse receptor. It is expressed in K cells in the small intestine and co-secreted with glucose-dependent insulinotropic polypeptide (GIP).2 Xenin-25 (1 µM) stimulates the release of insulin in BRIN-BD11 rat pancreatic β-cells in the presence of glucose and increases the insulinotropic response of glucagon-like peptide 1 (GLP-1), GIP, and neurotensin in the same cells.2 It prevents increases in plasma glucose levels in mice when administered 30 minutes before a subcutaneous injection of glucose. Xenin-25 inhibits gastric acid release stimulated by pentagastrin (Item No. 28546), increases pancreatic protein secretion, and stimulates contraction of the jejunum in anesthetized dogs.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Botto, J.M., Chabry, J., Sarret, P., et alStable expression of the mouse levocabastine-sensitive neurotensin receptor in HEK 293 cell line: Binding properties, photoaffinity labeling, and internalization mechanism. Biochem. Biophys. Res. Commun. 243(2), 585-590 (1998).

    2. Taylor, A.I., Irwin, N., McKillop, A.M., et alEvaluation of the degradation and metabolic effects of the gut peptide xenin on insulin secretion, glycaemic control and satiety. J. Endocrinol. 207(1), 87-93 (2010).

    3. Feurle, G.E., Heger, M., Niebergall-Roth, E., et alGastroenteropancreatic effects of xenin in the dog. J. Pept. Res. 49(4), 324-330 (1997).